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Abstract

Background
One of the most vulnerable populations to COVID-19 is women. Multiple factors associated with violence
against women (i.e. sexual assault, domestic violence, homelessness) create an increased vulnerability
for women during the COVID pandemic. Women also constitute the majority of older nursing home
residents and healthcare workers (e.g., nurses), who have the most pronounced exposure to COVID-19.
These factors combined with resource restraints like rationing and lack of access to healthcare can
further exacerbate women’s physical and psychological health issues. While literature has welldocumented challenges that women face during COVID-19, there is a lack of evidence-based solutions
that have the potential to mitigate these difficulties. Therefore, to address this issue, we aim to conduct a
systematic review of the literature to: (1) identify interventions designed for women in the context of
pandemics, (2) describe the characteristics and effects of these interventions concerning the distinctive
traits of women and pandemics, and (3) present evidence-based health solutions for women to mitigate
challenges they face amid and beyond COVID-19.

Methods
A systematic review of literature will be conducted on databases including PubMed, PsycINFO on the
EBSCO platform, CINAHL on the EBSCO platform, and Scopus, based on a search strategy developed in
consultation with an experienced medical librarian. Titles, abstracts, and full-text articles will be screened
against eligibility criteria developed a priori. The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses procedures will be adopted as the reporting framework, and data extracted (e.g.,
intervention details) will be evaluated by a multidisciplinary research team.

Results
NA for now—This is a protocol study.

Conclusions
Findings of this study will fill an important void in the literature. Considering that, in times of pandemic,
women are especially subject to grim health disparities, like pronounced exposure to COVID-19,
reproductive health issues, elevated domestic violence, increased mental health challenges, and lack of
access to healthcare services, the need for evidence-based health solutions that could address these
unique challenges is of paramount importance. A comprehensive understanding of the characteristics
and effects of health solutions available to women in the context of pandemics can also help researchers
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identify areas of improvement regarding intervention design and development. This may further
safeguard women’s health and wellbeing amid pandemics like COVID-19 and beyond.

Study Protocol Registration:
PROSPERO CRD42020194003

Background
COVID-19 has uprooted healthcare as we know it [3]. To date, COVID-19 has claimed over 20.4 million
confirmed cases and 745,000 deaths worldwide [4], leaving the world scrambling and struggling to find a
solution [5–7]. Similar to the severe acute respiratory syndrome or SARS and Middle East respiratory
syndrome or MERS, coronavirus disease 2019 or COVID-19 is a pandemic that has caused fear and
uncertainty across continents [8–10]. Different from SARS and MERS, COVID-19 has greater
transmissibility [11–13]. This, in turn, fuels its adverse impacts on societies at large as it leaves little time
for governments across the world to develop an effective plan to tackle the pandemic. While SARS,
MERS, and COVID-19 share similar virus characteristics [11–13], the epidemiological attributes of COVID19 make it more difficult to contain and control as the virus evolves [11–13], further allowing it to
continue wreaking havoc across the globe.
Mounting evidence shows that women are among the hardest hit populations during the pandemic [14–
18], especially non-white racial or ethnic communities such as black and Hispanic women [19, 20]. A
preliminary literature review indicates that factors influencing women’s increased vulnerability to COVID19 can be grouped into five primary contributors: (1) pronounced exposure to COVID-19, (2) issues related
to women’s reproductive health, (3) elevated domestic violence, (4) increased mental health challenges,
and (5) lack of access to healthcare services. A detailed illustration can be found in Fig. 1.
Related to the first, primary contributor studies have shown that older adults, especially older nursing
home residents and healthcare workers (e.g., nurses), have the most pronounced exposure to COVID-19
[1, 2]. Women make up the majority of both these populations [1, 21–23] leading them to an increased
probability and disproportionate risk of contracting COVID-19. It is estimated that, worldwide, women
make up 55% of the older adult (≥ 65 years old) population, whereas over 61% of the 80 years and older
population are women [24]. In the U.S., data show recent reports indicate that approximately 70.6% of
nursing home residents are women [21]. Nursing home residents often live with frailty and underlying
conditions [21], which makes them particularly susceptible to COVID-19 infection and deaths. Repeated
research indicates that nursing homes are ground zero in COVID-19 [2]. As of July 30, 2020, 44% of all
COVID-19 deaths in the U.S. occurred in nursing homes, which translates into 62,925 lives lost in total
[25]. Research also indicates that between 61.3–90.0% frontline healthcare professionals are women [1,
23, 26] and, in addition to an elevated risk of direct exposure to confirmed cases of COVID-19, most of
these healthcare professionals often face substantial mental health issues, such as anxiety, insomnia,
and depression [27, 28].
Page 3/18

The other primary factors that contribute to women’s pronounced vulnerability to COVID-19 are genderspecific [29–31] and are rooted in the historical and cultural social power imbalances that result from
being a patriarchal society, which disproportionately affects women, such as lower incomes and job loss
and violence against women [18, 32, 33]. Research indicates that women’s employment is 1.8 times more
likely to be in jeopardy due to COVID-19 compared to men. Even though women make up approximately
39% of the employed population globally, they count for 54% of all COVID-19-induced job losses [34].
Domestic violence victims are also disproportionately impacted by COVID-19. Violence against women, or
domestic violence, could be understood as “all behaviors which are based on gender, hurt, and damage,
resulted or possibly resulted in physical, sexual and mental damage and cause to oppress on women in
social or private life and arbitrary restrict the freedom of women” [35]. Domestic violence constituted a
health pandemic before the coronavirus outbreak [36–39]. Reports from the World Health Organization
indicate that, globally, 1 in 3 women is or will become a victim of physical or sexual violence at some
point in their relationship [40]. COVID-19 only serves to escalate this reality for women [32].
Mounting evidence shows that both incidence and death rates related to violence against women have
soared during the COVID-19 outbreak [32, 41–45]. In Australia, even though there was a 40% drop in
overall crime rates during the outbreak, domestic violence calls have increased 5% [46]. Available
evidence from European countries further indicates that there is a 60% spike of emergency calls from
female domestic violence victims during the COVID-19 outbreak [33]. Disturbing reports from the United
Kingdom (U.K.) suggest that between 23 March and 12 April, 2020, female deaths due to domestic
violence almost doubled compared with average rates in the past decade [47]. Compounding this effect is
that, citing COVID-19 infection risks, Governors in the U.S. have largely released perpetrators in jail for
misdemeanors [48], a categorization under which most domestic cases fall. This, in turn, may further
heighten the burden of fear and uncertainty some women shoulder amid COVID-19, if not increase their
odds of physical harm as well.
Undoubtedly, both health issues related to reproductive health and elevated domestic violence women
face can have a grim effect on women’s health during COVID-19, especially their mental health conditions
[30, 46, 49–52]. Repeated evidence indicates that women who are subject to domestic violence often
suffer from traumatic brain injuries (TBI) [53–55], which could have a long-term effect on their mental
health as well [56]. Examining the prevalence of TBI among a group of domestic violence victims,
researchers found that 88% of the women studied experienced more than one injury, and 81% of them
had experienced loss of consciousness due to their injuries [54]. Mounting research indicates that mental
health challenges domestic violence victims face may be even more disheartening [57–59]. Results from
a meta-analysis of 207 studies show that depression, anxiety, posttraumatic stress disorder, antisocial
personality disorder, and borderline personality disorder are common among domestic violence victims
[57]. However, due to spatial distancing measures and COVID-19 medical resources rationing policies,
many traditional venues of help, such as face-to-face consultation, have either been delayed or cancelled
[46, 50, 60–62]. In addition, it is well-documented that most domestic violence cases remain
underreported or unreported, because a considerable number of women do not seek help [32, 46, 50, 62,
63].
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It is not clear whether and to what degree women may benefit from the increasing number of technologybased health solutions proposed during the time of COVID-19. Older adults, the majority of whom are
women [24], often face issues associated with cognitive decline [64, 65], making them highly dependent
on physically-based healthcare services [66–68]. Furthermore, many older women face concurrent issues,
like visual impairment, hearing difficulties, or dual sensory loss [69, 70]. The majority of existing
technology-based health solutions fail to address these challenges given that they are primarily delivered
or hosted on websites and mobile applications [71–73].
Situations may be even worse for older domestic abuse victims. Research suggests that, amongst those
who have experienced concussions, a symptom common among domestic abuse victims, females are
more likely to develop computer-screen intolerance due to brain-related photosensitivity issues. In other
words, though technology-based solutions exist, due to lack of tailored design and consideration of older
users [74–76], these solutions may have limited utility and functionality for older females. All of these
barriers, in turn, can contribute to the most vulnerable of the population left with little to no access to
services [2, 46, 50, 62], especially factoring in the digital divide experienced by people who face both
health disparities and economic hardships which may further exacerbates these individuals’ unmet
healthcare needs [77–79]. These combined insights indicate that, while women face substantial health
issues amid COVID-19, most of these issues may remain unsolved for a prolonged period of time due to
lack of available health solutions [46, 50, 62]. This, undoubtedly will further worsen the dire situations
women face on a daily basis [46, 50, 62].
Overall, there is dearth of research that examines health solutions that have the potential to address
health issues people face amid COVID-19 [80], particularly for women. Available evidence indicates that
corollary interventions have the potential to address women’s health issues. Take the case of
interventions for human immunodeficiency virus (HIV). Researchers found that educator-led programs
based on the Health Belief Model yielded significantly more positive behavioral outcomes for females
living with HIV when compared to standard talk therapy [81]. One way to determine potentially effective
interventions for women during COVID-19 is to systematically review literature in the context of infectious
disease pandemics [80, 82, 83] as they share attributes such as unpredictability (e.g., when, where, and
how the crises unfold and fade) and destructiveness (e.g., uprooted lives and livelihoods) [11–13].
Communicable disease pandemics often share similar disaster preparedness procedures as well, like
social distancing measures [84–87]. Thus, interventions designed for women in the context of pandemics
like SARS and MERS may be able to shed light on solutions women can use amid COVID-19 as well.
To bridge this gap in literature, we aim to systematically review the literature to: (1) identify interventions
designed for women in the context of pandemics, (2) describe the characteristics and effects of these
interventions concerning the distinctive traits of women and pandemics, and (3) present evidence-based
and practical health solutions for women to mitigate challenges they face amid and beyond COVID-19.
Findings of this study will fill an important void in the literature. Considering that women are often subject
to grim health disparities, the need for evidence-based health solutions that could address the unique
challenges women face during COVID-19 is of paramount importance. A comprehensive understanding
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of the characteristics and effects of health solutions available to women in the context of pandemics can
also help researchers identify areas of improvement regarding intervention design and development.

Methods
To safeguard research rigor, the review was registered with the International Prospective Register of
Systematic Reviews database or PROSPERO (CRD42020194003) a priori. Furthermore, the Principles of
the Preferred Reporting Items for Meta-Analysis protocol (PRISMA) was adopted to guide reporting of this
systematic review [88]. As evidence indicates, these systematic review mechanisms are procedures
needed to avoid potential study duplication [89, 90], enhance research rigor [91, 92], improve study
comparability and replicability [93], and in turn, increase review quality and transparency [94].
Eligibility criteria
Eligibility criteria have two parts: inclusion and exclusion criteria. A list of inclusion criteria is
presented in Table 1. In the context of this study, the term pandemic is used to refer to both epidemics
and pandemics, which is defined as “the occurrence in a community or region of cases of an illness,
specific health-related behavior, or health-related events clearly in excess of normal expectancy” [95].
Specifically, this study is interested in epidemics or pandemics that are related to infectious diseases,
such as the Zika virus epidemic, the Ebola outbreak, the H1N1 epidemic, the SARS pandemic, the MERS
epidemic, and the COVID-19 pandemic. The female gender and the term woman or women are used
interchangeably in this study and is defined as individuals with the female biological attributes, including
chromosomes, anatomy, and hormones [96]. An intervention is defined as a persuasive strategy or
program that has the potential to induce positive changes in people’s health-related attitudes and
behavior. Overall, studies will be excluded if they: (1) did not focus on women or have a ≥ 50% female
population (2) did not conduct in the context of an infectious disease-induced pandemic (3) did not
empirically evaluate an intervention in the form of randomized controlled trials (e.g., technology-based or
non-technology-based interventions), (4) did not report descriptions of the interventions studied), and (5)
did not report empirical research findings (e.g., effects of the interventions).

Search strategy
Our key search terms centered on three concepts: women’s health, interventions, and pandemics.
The search term was developed with consultation with an academic librarian. An example PubMed
search string is included in Table 2. Search strings will be subsequently applied to databases including
PubMed, PsycINFO, CINAHL, and Scopus. The search will be conducted in September, 2020. In addition to
database searches, we will also manually search reference lists of the included articles to identify
additional eligible papers.
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An experienced medical librarian will search published literature and unpublished studies for records
discussing technology-based health interventions, pandemics, and women. The librarian will create
search strategies using a combination of key words and controlled vocabulary in: PubMed 1946-; CINAHL
on the EBSCO platform 1937-; PsycINFO on the EBSCO platform 1927-; Scopus 1966-; and
clinicaltrials.gov 1997- present. Search results will not be limited by language or year. No database limits
or filters will be applied. An initial search string was built and tested in PubMed in August of 2020 and is
included in Table 2.

Study selection
Upon search completion, citations will be uploaded to Rayyan [97], with duplicates removed. Titles
and abstracts will be screened by two principle reviewers against the eligibility criteria. This process will
be administered in a double-blind fashion, as Rayyan allows the reviewing process to be blinded. After
removing ineligible articles, the same review process will be applied to full-text articles for further review.
Detailed reasons for exclusion will be recorded in the PRISMA flowchart. Discrepancies between reviewers
will be resolved via group discussions.
Study quality assessment
Quality of eligible studies will be evaluated with the Cochrane Collaboration evaluation framework
to determine risk of bias [98]. In total, there are seven domains to the framework: (1) random sequence
generation, (2) allocation concealment, (3) blinding of participants and personnel, (4) blinding of
outcome assessment, (5) incomplete outcome data, (6) selective reporting, and (7) other source of bias.
Only scores of the first five items will be used for the risk evaluation [98]. A study will only be considered
having a low or a high risk of bias if a “low” rating was given on three or more of these five items [98, 99].
Two reviewers will evaluate risk of bias of all included studies independently. Group discussions will be
used to resolve any potential discrepancies till a consensus is reached.
Data extraction and synthesis
To address the research aim, a comprehensive list of data will be extracted, including study
characteristics (e.g., country of origin, study methods, and research purpose), sample characteristics (e.g.,
age, race/ethnicity, and disease history), interventions evaluated (e.g., intervention stimuli, intervention
exposure, and weather the design of the intervention material is tailored to women or the
epidemic/pandemic context), outcome variables assessed (e.g., before-after health outcome changes), as
well as principal research findings. Data extraction will be conducted by all authors. Descriptive analysis
will be used to shed light on the patterns among included articles (e.g., country of origin distribution),
whereas narrative synthesis will be adopted to investigate the characteristics and effects of the
interventions. A preliminary search found great heterogeneity within studies. Therefore, meta-analysis will
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only be considered once a more grounded understanding of the characteristics of included articles is
reached.

Results
NA for now: This is a protocol study

Discussions
Women belong to one of the most vulnerable communities to the COVID-19 pandemic [14–18]. While
useful insights are available in the literature, there is a lack of evidence-based health solutions that can
be applied to help women alleviate health issues they face amid COVID-19. Therefore, to address this
issue, we aim to systematically review the literature to: (1) identify interventions designed for women in
the context of pandemics, (2) describe the characteristics and effects of these interventions concerning
the distinctive traits of women and pandemics, and (3) present evidence-based and practical health
solutions for women to mitigate challenges they face amid and beyond COVID-19. Findings of our review
will be able to offer timely solutions that have the potential to alleviate health challenges women
shoulder amid the pandemic.
To our best knowledge, this is the first systematic review that examines evidence-based solutions
developed and evaluated in the context of epidemics and pandemics, with the aim to find solutions that
can shed light on issues women face amid COVID-19. We expect findings of this study can help women
better shoulder the adverse impacts of the pandemic. Based on effective solutions identified from the
planned review, results of this study can also help researchers better design and develop health solutions
that are tailored to the unique challenges women face amid COVID-19. Furthermore, we also expect to
find potential areas for improvement within the literature as directions for future research endeavors.
Preliminary search results indicate that interventions tailored to women in the context of epidemics or
pandemics are often not technology-based, which indicates that their applicability in the context of
COVID-19 might be compromised. Technology-based interventions can be understood as "the use of
technology to manage or support health promotion strategies that aim to produce accessible and
affordable health solutions to a target audience" [100]. Considering the physical constraints introduced
by measures such as lockdowns and social distancing, a lack of technology integration among available
health solutions may limit their abilities to mitigate health challenges women face amid COVID-19.
Overall, we believe findings of the planned review will be able to offer evidence needed to address health
issues women face amid COVID-19 and beyond.

Conclusions
NA for now: This is a protocol study

List Of Acronyms
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COVID-19: coronavirus disease 2019
MERS: Middle East respiratory syndrome or MERS-CoV-2
SARS: severe acute respiratory syndrome or SARS-CoV
U.K.: United Kingdom
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Tables
Table 1. Study inclusion criteria
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Category

Criteria

Study
population

Women who are 18 years and older (≥50% of the whole population studied)

Study
context

Infectious disease-induced pandemics

Health
solution

Health solutions are defined as non-pharmaceutical interventions that are designed to
change women's disaster preparedness amid pandemics

Key
variable

Detailed descriptions of the health solutions (i.e., purpose of the intervention,
intervention stimuli, application of the interventions, intervention exposure, outcome
variables assessed/measured, and weather the design of the intervention material is
tailored to women or the epidemic/pandemic context)

Study type

Original research (i.e., research that reports original and empirical research findings)

Research
design

Randomized controlled trials

Outcome

Empirical reporting of the characteristics and effect of the health solutions (i.e., beforeafter effects on women’s mental health)

Table 2. Example PubMed search string
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Concept

Search string

Women

“women”[MeSH] OR “women”[TIAB] OR “woman”[TIAB] OR “women s”[TIAB] OR
“woman s”[TIAB] OR “female”[MeSH] OR “female”[TIAB] OR “females”[TIAB] OR
"Mothers"[Mesh] OR "Surrogate Mothers"[Mesh] OR motherhood[TIAB] OR
mothering[TIAB] OR mother[TIAB]

Pandemics

Randomized
controlled
trials

“pandemics”[MeSH] OR “pandemic”[TIAB] OR “pandemics”[TIAB] OR
“epidemics”[MeSH] OR “epidemic”[TIAB] OR “epidemics”[TIAB] OR "SARS Virus"[Mesh]
OR SARS[TIAB] OR "Coronavirus Infections"[Mesh:NoExp] OR MERS[TIAB] OR
MERS[OT] OR "Influenza Pandemic, 1918-1919"[Mesh] OR "COVID-19"[Supplementary
Concept] OR "Hemorrhagic Fever, Ebola"[Mesh] OR "Ebolavirus"[Mesh] OR ebola[TIAB]
OR ebola[OT] OR “severe acute respiratory syndrome”[TIAB] OR "Severe Acute
Respiratory Syndrome"[Mesh] OR “Middle East Respiratory Syndrome”[TIAB] OR
“covid”[TIAB] OR “Spanish flu”[TIAB] OR “Spanish flu”[OT] OR “Spanish
influenza”[TIAB] OR (H1N1[TIAB] AND pandemic[TIAB]) OR (novel[TIAB] AND
coronavirus[TIAB]) OR ((coronavirus[TIAB] OR "corona virus"[TIAB] OR
coronavirinae[TIAB] OR coronaviridae[TIAB] OR betacoronavirus[TIAB] OR
covid19[TIAB] OR "covid 19"[TIAB] OR nCoV[TIAB] OR "CoV 2"[TIAB] OR CoV2[TIAB]
OR sarscov2[TIAB] OR 2019nCoV[TIAB] OR "novel CoV"[TIAB] AND ("severe acute
respiratory"[TIAB] OR pneumonia[TIAB]) AND (outbreak[TIAB])) OR "Coronavirus"
[Mesh] OR "Coronavirus Infections"[Mesh] OR "COVID-19"[Supplementary Concept] OR
"severe acute respiratory syndrome coronavirus 2"[Supplementary Concept] OR
"Betacoronavirus"[Mesh])

"Randomized Controlled Trial" [Publication Type] OR "Randomized Controlled Trials as
Topic"[Mesh] OR "Controlled Clinical Trial" [Publication Type] OR
randomized[Title/Abstract] OR randomised[Title/Abstract] OR
randomly[Title/Abstract] OR “random* assign*”[Title/Abstract] OR trial*
[Title/Abstract]
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Figure 1
Main contributors to women’s vulnerability to COVID-19
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